Resilience was founded in 2020 by Drew Oetting, Patrick Yang, Sandesh Mahatme, and Rahul Singhvi. Resilience has not officially endorsed a plan to participate in an IPO.

Resilience is a biotechnology company with a mission to streamline manufacturing processes for complex medicines. Per Forge data, Resilience raised $2.5 billion in funding over 7 rounds. Their latest funding was raised on Mar 24, 2023. Key investors include ARCH Venture Partners, 8VC, Mubadala, Magnetic Ventures, and the U.S. Department of Defense.

These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.

Register for Details

For more details on financing and valuation for Resilience, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Resilience

Forge green plus iconForge green minus icon

What is Resilience's IPO price?

The IPO price for Resilience will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Resilience?

Resilience is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Resilience shares pre-IPO?

If you own Resilience pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Resilience a publicly traded company?

Resilience is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

What is Resilience's funding to date?

Resilience has raised $2.03B to date.
Forge green plus iconForge green minus icon

When was Resilience founded?

Resilience was founded in 2020.

Who are Resilience's major investors?

New Enterprise Associates
Dragoneer Investment Group
Lux Capital
Koch Disruptive Technologies
Arch Venture Partners
Raptor Group
Dragoeer Investment Group
Mubadala Investment Company
Catalio Capital Management
Pfizer Ventures
R-Squared Ventures
Global Health Investment Fund

Resilience Funding Rounds and Last Known Valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
6/6/2022 Series D $625MM raised $XXX.XX $XXX.XX
5/15/2021 Series C $600MM raised $XXX.XX $XXX.XX
11/23/2020 Series B $755MM raised $XXX.XX $XXX.XX
4/17/2020 Series A-1 and A-2 $54.28MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: May 23, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.